BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2051337)

  • 1. Effect of glutathione depletion on the in vivo inhibition of drug metabolism by agents forming an inactive cytochrome P-450 Fe(II):metabolite complex. Studies with amiodarone and troleandomycin.
    Svensson CK; Drobitch RK; Kloss KA
    J Pharm Sci; 1991 Mar; 80(3):225-8. PubMed ID: 2051337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glutathione turnover in drug sulfation: differential effects of diethylmaleate and buthionine sulfoximine on the pharmacokinetics of acetaminophen in the rat.
    Galinsky RE
    J Pharmacol Exp Ther; 1986 Jan; 236(1):133-9. PubMed ID: 3941389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
    Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans.
    Pessayre D; Larrey D; Vitaux J; Breil P; Belghiti J; Benhamou JP
    Biochem Pharmacol; 1982 May; 31(9):1699-704. PubMed ID: 6980648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
    Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
    Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
    Manning BW; Franklin MR; Galinsky RE
    Drug Metab Dispos; 1991; 19(2):498-502. PubMed ID: 1676661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in conjugative enzyme activity and acetaminophen metabolism in young and senescent male F-344 rats following prolonged exposure to buthionine sulfoximine.
    Galinsky RE; Manning BW; Kimura RE; Franklin MR
    Exp Gerontol; 1992; 27(2):221-32. PubMed ID: 1521595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione.
    Thomassen D; Slattery JT; Nelson SD
    J Pharmacol Exp Ther; 1990 May; 253(2):567-72. PubMed ID: 2338648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral depletion of testicular glutathione levels in the rat following intratesticular injections of diethylmaleate and buthionine sulfoximine.
    Slott VL; Linder RE; Strader LF; Perreault SD
    Toxicol Appl Pharmacol; 1989 Apr; 98(2):369-73. PubMed ID: 2711398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine.
    Malaker K; Hurwitz SJ; Bump EA; Griffith OW; Lai LL; Riese N; Coleman CN
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):407-12. PubMed ID: 7910818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the glutathione-depleting agents diethylmaleate, phorone and buthionine sulfoximine on biliary copper excretion in rats.
    Nederbragt H
    Biochem Pharmacol; 1989 Oct; 38(20):3399-406. PubMed ID: 2818632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glutathione turnover in the rat: effect of fasting and buthionine sulfoximine.
    Hum S; Robitaille L; Hoffer LJ
    Can J Physiol Pharmacol; 1991 May; 69(5):581-7. PubMed ID: 1863907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of buthionine sulfoximine, an inhibitor of glutathione synthesis, on hepatic drug metabolism in the male mouse.
    White RD; Norton R; Bus JS
    Toxicol Lett; 1984 Oct; 23(1):25-32. PubMed ID: 6485015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):132-9. PubMed ID: 7839360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity after 3'-hydroxyacetanilide administration to buthionine sulfoximine pretreated mice.
    Tirmenstein MA; Nelson SD
    Chem Res Toxicol; 1991; 4(2):214-7. PubMed ID: 1782350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of macrolide antibiotics on drug metabolism in rats and in humans.
    Pessayre D
    Int J Clin Pharmacol Res; 1983; 3(6):449-58. PubMed ID: 6381341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of heme oxygenase-1 synthesis by glutathione depletion in Chinese hamster ovary cells.
    Saunders EL; Maines MD; Meredith MJ; Freeman ML
    Arch Biochem Biophys; 1991 Aug; 288(2):368-73. PubMed ID: 1898036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glutathione depletion on aminopyrine and formaldehyde metabolism.
    Bhatt HS; Lober SB; Combes B
    Biochem Pharmacol; 1988 Apr; 37(8):1581-9. PubMed ID: 3358787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.